Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Jellagen launches JellaGel™, the first Collagen Type 0 Hydrogel taking on the market leading Extracellular Matrix

Jellagen® Limited, a biotechnology company manufacturing high-value Collagen Type 0 derived from jellyfish, announce the launch of their JellaGel™ Hydrogel.

From Jellagen 15 Jan 2021

New DNA test quickly identifies secondary infections in COVID-19 patients

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

15 Jan 2021

Targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers

Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers (TNBC) to trigger tumor cell death and signal the body's immune response.

15 Jan 2021

Omega-3 diet helps Arctic ground squirrels to hibernate a little warmer than normal

By feeding arctic ground squirrels special diets, researchers have found that omega-3 fatty acids, common in flax seed and fish oil, help keep the animals warmer in deep hibernation.

15 Jan 2021

Lab study reveals effective treatment for COVID-19

A new potential therapy for COVID-19 developed by researchers at Rush University Medical Center has shown success in preventing the disease's symptoms in mice.

14 Jan 2021

Excess COVID-19 deaths in overwhelmed Israeli hospitals

Researchers in Israel have conducted a study showing that increased hospital load due to rising coronavirus disease 2019 (COVID-19) cases resulted in higher COVID-19-related mortality, despite hospitals not exceeding their defined threshold for meeting patients' treatment needs.

14 Jan 2021

A snake venom enzyme shows anti-SARS-CoV-2 activity in vitro

A new study reports the virucidal and fusion-inhibiting attributes of snake venom against the COVID-19 agent SARS-CoV-2.

14 Jan 2021

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

The unchecked advance of COVID-19 has made it a top public health priority to produce a vaccine capable of inducing a safe and powerful protective response against its causative pathogen: SARS-CoV-2. An encouraging new study shows the immunogenicity, safety, and protective efficacy, of a Newcastle disease virus (NDV)-based intranasal vector vaccine in animal studies.

14 Jan 2021

Influenza drug enisamium a potential COVID-19 treatment

Researchers in Europe and the United States have demonstrated the potential of the influenza drug enisamium as a treatment for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

13 Jan 2021

COVID-19 survivors can show persistent symptoms six months after recovery, study finds

A team of researchers conduct a large study exploring the persistence of COVID-19 symptoms in recovered patients.

13 Jan 2021

Moderna to develop three new mRNA-based vaccines against HIV, influenza, and the Nipah virus

Morderna has announced plans to develop a range of new mRNA-based vaccines against other viruses, including the influenza virus, human immunodeficiency virus (HIV), and the Nipah virus.

13 Jan 2021

New N501 SARS-CoV-2 mutation may have been circulating in Italy since August 2020

A recent study shows that mutated SARS-CoV-2 strains with a substitution at position 501 might have circulated unnoticed even before the end of September 2020, when the rapid emergence of B.1.1.7 lineage (carrying the N501Y mutation) was initially reported.

13 Jan 2021

Researchers use urine test to identify and verify a patient's type of asthma

In a new study, researchers at Karolinska Institutet in Sweden have used a urine test to identify and verify a patient's type of asthma.

13 Jan 2021

Study summarizes effectiveness of cloth masks in protecting clinicians from COVID-19

A rapid, evidence-based review summarizes the effectiveness of cloth masks in protecting health care clinicians from respiratory viral infections, such as COVID-19. Nine studies were included in the review, and all but one were conducted prior to the COVID-19 pandemic.

13 Jan 2021

Study outlines steps to prepare patients for elective surgery following COVID-19

Acknowledging that COVID-19 may be here to stay, Oregon Health & Science University has laid out a series of steps to prepare patients for elective surgery following their illness.

13 Jan 2021

SARS-CoV-2 may join the ranks of mild cold-causing coronaviruses

What is the endgame for SARS-CoV-2, the virus that is causing worldwide devastation? If it becomes endemic -- circulating in the general population -- and most people are exposed in childhood, SARS-CoV-2 may join the ranks of mild cold-causing coronaviruses that currently circulate in humans, according to a model developed by Emory and Penn State scientists.

13 Jan 2021

Medical institutions should support health care workers with COVID-19 infection, say experts

By mid-November, the Centers for Disease Control and Prevention had reported that 218,439 health care workers in the U.S. had been infected with COVID-19 -- a likely underestimate due to incomplete data from states.

13 Jan 2021

Study: 82% respondents ventilate more frequently to protect themselves from corona

Despite cold temperatures, the population counts on fresh air to avoid contracting the coronavirus. This is shown by the results of the 26th edition of the BfR-Corona-Monitor, a regular survey by the German Federal Institute for Risk Assessment (BfR). In all age groups, about four out of five respondents say they ventilate more frequently.

13 Jan 2021

Biologists reveal unusual structure of coronavirus protein linked to immune evasion

A team of HIV researchers, cellular biologists, and biophysicists who banded together to support COVID-19 science determined the atomic structure of a coronavirus protein thought to help the pathogen evade and dampen response from human immune cells.

13 Jan 2021

Scientists identify sensor in human lungs that detects SARS-CoV-2

Scientists at Sanford Burnham Prebys Medical Discovery Institute have identified the sensor in human lungs that detects SARS-CoV-2 and signals that it's time to mount an antiviral response.

13 Jan 2021

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Jellagen launches JellaGel™, the first Collagen Type 0 Hydrogel taking on the market leading Extracellular Matrix

New DNA test quickly identifies secondary infections in COVID-19 patients

Targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers

Omega-3 diet helps Arctic ground squirrels to hibernate a little warmer than normal

Lab study reveals effective treatment for COVID-19

Excess COVID-19 deaths in overwhelmed Israeli hospitals

A snake venom enzyme shows anti-SARS-CoV-2 activity in vitro

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

Influenza drug enisamium a potential COVID-19 treatment

COVID-19 survivors can show persistent symptoms six months after recovery, study finds

Moderna to develop three new mRNA-based vaccines against HIV, influenza, and the Nipah virus

New N501 SARS-CoV-2 mutation may have been circulating in Italy since August 2020

Researchers use urine test to identify and verify a patient's type of asthma

Study summarizes effectiveness of cloth masks in protecting clinicians from COVID-19

Study outlines steps to prepare patients for elective surgery following COVID-19

SARS-CoV-2 may join the ranks of mild cold-causing coronaviruses

Medical institutions should support health care workers with COVID-19 infection, say experts

Study: 82% respondents ventilate more frequently to protect themselves from corona

Biologists reveal unusual structure of coronavirus protein linked to immune evasion

Scientists identify sensor in human lungs that detects SARS-CoV-2

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in